Multiple Sclerosis Clinical Trial

Observational Study to Establish Patient-Matched Population Norms for the Multiple Sclerosis Cognition Assessment Battery

Summary

The primary objective of the study is to develop MS patient-matched healthy population norms for the Multiple Sclerosis Cognition Assessment Battery (MS-COG) that are representative of the United States (US), France, and Italy.

View Eligibility Criteria

Eligibility Criteria

Key Inclusion Criteria

Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use confidential health information in accordance with national and local subject privacy regulations.
Must be in good health as determined by the Investigator, based on medical history, physical examination, and Screening evaluations.
Must be a native language speaker of the country where the study is being conducted.

Key Exclusion Criteria:

Neurological illnesses/conditions, such as motor or vocal tics (including a diagnosis of Tourette's syndrome), head trauma with significant loss of consciousness (>30 min), cerebral ischemia, carotid artery disease, epilepsy, brain tumor, dementia (including mild cognitive impairment and Alzheimer's disease), chronic meningitis, multiple sclerosis, pernicious anemia, normal-pressure hydrocephalus, HIV infection, Parkinson's disease, and Huntington's disease.
Medical illnesses/conditions that may affect brain function, such as untreated hypertension (blood pressure >140/100 mm Hg), cardiac disease, insulin-dependent diabetes mellitus, endocrine disorders, renal disease, glaucoma, and chronic obstructive pulmonary disease.
Major psychiatric disturbance according to the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (US) Axis I criteria [American Psychiatric Association 2013] and the International Statistical Classification of Diseases and Related Health Problems, 10th revision Axis I criteria (Europe) [WHO 2010].
History of developmental disorders.

Note: Other protocol defined Inclusion/ Exclusion criteria may apply.

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

467

Study ID:

NCT02283918

Recruitment Status:

Completed

Sponsor:

Biogen

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 8 Locations for this study

See Locations Near You

Research Site
Thornton Colorado, 80233, United States
Research site
Decatur Georgia, 30033, United States
Research Site
Latham New York, 12110, United States
Research Site
Akron Ohio, 44320, United States
Research site
Marseille Cedex 5 Bouches-du-Rhône, 13385, France
Research site
Bordeaux Gironde, 33076, France
Research site
Milano , 20162, Italy
Research site
Roma , 179, Italy

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

467

Study ID:

NCT02283918

Recruitment Status:

Completed

Sponsor:


Biogen

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider